--- title: "UK Regulator OKs New Pneumonia, Meningitis Vaccine" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/240496896.md" description: "Merck Sharp & Dohme (UK)'s Capvaxive secured marketing authorization from the UK Medicines and Healthcare products Regulatory Agency as a vaccine against illnesses caused by bacteria called Streptococcus pneumoniae or pneumococcus. The vaccine, approved through the international recognition procedure, protects individuals aged 18 years and older against illnesses like pneumonia, meningitis and bacteraemia, according to a Thursday release. The agency noted it will keep the vaccine's safety and effectiveness under review." datetime: "2025-05-16T04:15:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/240496896.md) - [en](https://longbridge.com/en/news/240496896.md) - [zh-HK](https://longbridge.com/zh-HK/news/240496896.md) --- > 支持的语言: [English](https://longbridge.com/en/news/240496896.md) | [繁體中文](https://longbridge.com/zh-HK/news/240496896.md) # UK Regulator OKs New Pneumonia, Meningitis Vaccine Merck Sharp & Dohme (UK)'s Capvaxive secured marketing authorization from the UK Medicines and Healthcare products Regulatory Agency as a vaccine against illnesses caused by bacteria called Streptococcus pneumoniae or pneumococcus. The vaccine, approved through the international recognition procedure, protects individuals aged 18 years and older against illnesses like pneumonia, meningitis and bacteraemia, according to a Thursday release. The agency noted it will keep the vaccine's safety and effectiveness under review. ### 相关股票 - [Merck (MRK.US)](https://longbridge.com/zh-CN/quote/MRK.US.md) - [Definitive Healthcare (DH.US)](https://longbridge.com/zh-CN/quote/DH.US.md) - [Unitedhealth (UNH.US)](https://longbridge.com/zh-CN/quote/UNH.US.md) - [Sharp Corporation (6753.JP)](https://longbridge.com/zh-CN/quote/6753.JP.md) ## 相关资讯与研究 - [Merck Says EU Approves Keytruda Combination Regimen for Platinum-Resistant Ovarian Cancer](https://longbridge.com/zh-CN/news/281517399.md) - [Infinimmune, Merck enter into antibody discovery pact](https://longbridge.com/zh-CN/news/281193725.md) - [EU approves Merck Keytruda-paclitaxel regimen for PD-L1+ platinum-resistant ovarian cancer](https://longbridge.com/zh-CN/news/281509049.md) - [Hershey Stock (HSY) Looks Sweeter After Company Promises Return to Classic Reese's](https://longbridge.com/zh-CN/news/281415413.md) - [WESPAC Advisors LLC Makes New $2.93 Million Investment in Merck & Co., Inc. $MRK](https://longbridge.com/zh-CN/news/281011423.md)